MorphoSys AG (MOR) Tops Q3 EPS by 173c

MorphoSys AG (NASDAQ: MOR) reported Q3 EPS of EUR1.22, EUR1.73 better than the analyst estimate of (EUR0.51). Revenue for the quarter came in at EUR59 million versus the consensus estimate of EUR64.11 million.

For earnings history and earnings-related data on MorphoSys AG (MOR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c